Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member] Series A Preferred Stock [Member]	Preferred Stock [Member] Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Subscription Receivable [Member]	AOCI Attributable to Parent [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2020	$ 5		$ 341	$ 119,650	$ (2,504,893)		$ 27,721		$ (2,357,176)
Balance, shares at Dec. 31, 2020	50,000		3,412,281
Shares of stock issued for cash			$ 7	494,493					494,500
Shares of stock issued for cash, shares			75,625
Shares of stock issued for conversion of notes payable and accrued interest			$ 8	427,560					427,568
Shares of stock issued for conversion of notes payable and accrued interest, shares			83,773
Shares of stock issued for services rendered			$ 18	1,344,977					1,344,995
Shares of stock issued for services rendered, shares			178,875
Shares of stock issued for acquisition of Rohuma (second tranche)			$ 32	2,049,789					2,049,821
Shares of stock issued for acquisition of Rohuma (second tranche), shares			320,285
Shares of stock issued for providing note payable			$ 4	446,996					447,000
Shares of stock issued for providing note payable, shares			37,500
Conversion of Series A Preferred Stock to Common Stock	$ (5)		$ 1	$ 4
Conversion of Series A Preferred Stock to Common Stock, shares	(50,000)		6,899
Shares of stock issued in warrant exercises			6	39					45
Shares of stock issued in warrant exercises, shares			56,400
Stock-based compensation on granting of options				$ 412,447					$ 412,447
Stock-based compensation - warrants granted for consulting				122,070					122,070
Stock-based compensation for restricted stock grants (shares not issued)				106,638					106,638
Warrants earned for acquisition of Mimo				984,268					984,268
Net loss for the period					(6,448,875)		2,884	(4,488)	$ (6,450,479)
Shares of stock issued upon exercise of stock options, shares
Balance at Dec. 31, 2021			$ 417	6,508,931	(8,953,768)		30,605	(4,488)	$ (2,418,303)
Balance, shares at Dec. 31, 2021			4,171,638
Shares of stock issued for acquisition of Rohuma (second tranche)			$ 13	$ 851,340					$ 851,353
Shares of stock issued for acquisition of Rohuma (second tranche), shares			133,024
Shares of stock issued in warrant exercises			23	120					143
Shares of stock issued in warrant exercises, shares			228,309
Stock-based compensation on granting of options				$ 57,590					$ 57,590
Stock-based compensation for restricted stock grants (shares not issued)				87,341					87,341
Warrants earned for acquisition of Mimo				410,112					410,112
Net loss for the period					(9,171,556)				(9,171,556)
Fractional share adjustment
Fractional share adjustment, shares			1,370
Shares of stock issued with convertible debt				11,853					11,853
Shares of stock issued with convertible debt, shares			3,000
Shares of stock issued upon exercise of stock options			$ 39	49,965					$ 50,004
Shares of stock issued upon exercise of stock options, shares			394,219						394,065
Shares of stock issued upon exercise of restricted stock grants			$ 17	393,686					$ 393,703
Shares of stock issued upon exercise of restricted stock grants, shares			168,750
Shares of stock issued upon conversion of debt		$ 22	$ 1,301	7,532,576					7,533,899
Shares of stock issued upon conversion of debt, shares		220,135	13,002,729
Cancelled warrants				1,241					1,241
Deconsolidation of subsidiaries					602,538		(30,605)	4,488	576,421
Balance at Dec. 31, 2022		$ 22	$ 1,810	$ 15,904,755	$ (17,522,786)				$ (1,616,199)
Balance, shares at Dec. 31, 2022		220,135	18,103,039